UK team evaluates "grow-your-own" cartilage to repair damaged knees
This article was originally published in Clinica
Surgeons in the UK are for the first time offering National Health Service patients a treatment for cartilage injuries in which samples of the patient's own tissue are grown in a laboratory and transplanted back in the knee.
You may also be interested in...
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.
C&D CEO Matthew Farrell says Zicam has 73% share in the US zinc-containing wellness product market. It's acquiring marketer Matrixx Initiatives at a price almost 15 times Zicam brand’s projected 2021 EBITDA.